No abstract available
Publication types
-
Clinical Trial
-
Comment
-
Comparative Study
-
Letter
-
Randomized Controlled Trial
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Antithrombin III / analysis
-
Asparaginase / administration & dosage
-
Blood Coagulation* / drug effects
-
Cyclophosphamide / administration & dosage
-
Daunorubicin / administration & dosage
-
Fibrinogen / metabolism
-
Fibrinolysin / analysis
-
Fibrinopeptide A / analysis
-
Humans
-
Peptide Hydrolases / analysis
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / blood*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Prednisone / administration & dosage
-
Prospective Studies
-
Prothrombin / analysis
-
Vincristine / administration & dosage
-
alpha-2-Antiplasmin / analysis
Substances
-
alpha-2-Antiplasmin
-
antithrombin III-protease complex
-
Fibrinopeptide A
-
Vincristine
-
Cyclophosphamide
-
Antithrombin III
-
Prothrombin
-
Fibrinogen
-
Peptide Hydrolases
-
Fibrinolysin
-
Asparaginase
-
Prednisone
-
Daunorubicin